Anterior midcingulate cortex activity during pain catastrophizing predicts and sequentially tracks reduction in pain interference after cognitive behavioral therapy in fibromyalgia
Abstract
Abstract: Fibromyalgia (FM) is a chronic pain disorder characterized by widespread pain, fatigue, and functional disability. Cognitive behavioral therapy (CBT) has been shown to alleviate FM symptoms, but the neural mechanisms underlying CBT's effectiveness in reducing functional impact remain unclear. In this study, we investigated the temporal dynamics of clinical and neural responses to CBT. We conducted a longitudinal randomized controlled neuroimaging trial with 98 patients with FM assigned to an 8-week CBT or education intervention. Functional MRI (fMRI) data were collected at baseline (PRE), midtreatment (MID, at 4 weeks), and post-treatment (POST) while participants engaged in task-evoked pain catastrophizing during the fMRI scan session. Clinical outcomes, including pain interference and catastrophizing, were assessed at all time points. The CBT group demonstrated early (MID-PRE, P < 0.05) and late (POST-MID, P < 0.005) reductions in pain interference and catastrophizing. Anterior midcingulate cortex (aMCC) activity during pain catastrophizing task tracked symptom improvement over time and predicted early vs late improvements over the 8-week course of CBT. Moreover, machine learning models indicated that baseline aMCC activation was a more accurate predictor of treatment response than baseline levels of patient-reported pain and catastrophizing. This study provides evidence that brain activity during pain catastrophizing plays a critical role in tracking and…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 98 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.